<DOC>
	<DOCNO>NCT00004150</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know chemotherapy regimen effective colon cancer . PURPOSE : This randomized phase III trial study high-dose fluorouracil without leucovorin see well work compare standard-dose fluorouracil leucovorin treat patient undergone surgery stage III colon cancer .</brief_summary>
	<brief_title>High-Dose Fluorouracil With Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery Treating Patients With Stage III Colon Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare recurrence-free survival duration survival patient stage III adenocarcinoma colon treat adjuvant high-dose fluorouracil without leucovorin calcium versus standard fluorouracil leucovorin calcium follow curative radical resection . - Compare safety regimens patient population . OUTLINE : This randomize , multicenter study . Patients stratify accord regional lymph node involvement ( N1 ( 1-3 pericolic lymph node ) vs N2 ( 3 pericolic lymph node ) participate center . Patients randomize one two treatment arm . - Arm I : Patients receive leucovorin calcium IV follow fluorouracil IV day 1-5 . Treatment repeat every 4 week 6 course . - Arm II : Patients receive high-dose fluorouracil IV continuously 48 hour weekly 8 week . Treatment repeat every 8 week 3 course . OR - Patients receive leucovorin calcium IV 2 hour follow fluorouracil IV continuously 24 hour weekly 6 week . Treatment repeat every 7 week 3 course . OR - Patients receive leucovorin calcium IV 2 hour follow fluorouracil IV bolus fluorouracil IV continuously 22 hour day 1 2 . Treatment repeat every 2 week 12 course . Patients follow 1 month , every 6 month 4.5 year , annually thereafter death . PROJECTED ACCRUAL : Approximately 1,600 patient ( 800 per treatment arm ) accrue study within 3 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage III adenocarcinoma mucinous adenocarcinoma colon Must curative radical resection within 56 day prior study No local tumor therapy ( i.e. , polypectomy , local excision limit intestinal resection ) PATIENT CHARACTERISTICS : Age : 18 Performance status : WHO 01 Life expectancy : Not specify Hematopoietic : WBC least 3,500/mm^3 Platelet count least 100,000/mm^3 Hemoglobin great 10.0 g/dL Hepatic : Bilirubin great 2.0 mg/dL Renal : Creatinine great 1.5 mg/dL Cardiovascular : No severe coronary heart disease No New York Heart Association class III IV heart failure Other : No malignancy within past 10 year except adequately treat basal cell skin cancer carcinoma situ cervix No uncontrolled infection No severe disease No known allergy leucovorin calcium No know familial adenomatous polyposis , Crohn 's disease , ulcerative colitis No hereditary syndrome ( e.g. , Gardner 's syndrome , Turcot 's syndrome , hereditary nonpolyposis colon cancer ) Not pregnant nursing Fertile patient must use effective contraception 6 month study participation PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy colon cancer Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy colon cancer Surgery : See Disease Characteristics Other : No concurrent systemic anticancer therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2001</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>mucinous adenocarcinoma colon</keyword>
</DOC>